المؤلفون: Brunekreeft KL; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Paijens ST; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Wouters MCA; Trev and Joyce Deeley Research Centre, BC Cancer, BC Cancer, Victoria, Canada., Komdeur FL; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Eggink FA; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Lubbers JM; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Workel HH; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Van Der Slikke EC; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Pröpper NEJ; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Leffers N; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Adam J; Department of Clinical Biology, Institut De Cancérologie Gustave Roussy, Paris, France., Pijper H; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Plat A; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Kol A; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., Nijman HW; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands., De Bruyn M; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, The Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2020 May 13; Vol. 9 (1), pp. 1760705. Date of Electronic Publication: 2020 May 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology

مواضيع طبية MeSH: Neoadjuvant Therapy* , Ovarian Neoplasms*/drug therapy, Carcinoma, Ovarian Epithelial/drug therapy ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating ; Retrospective Studies ; Tumor Microenvironment

المؤلفون: Komdeur FL; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Wouters MC; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Medical Microbiology, The Netherlands., Workel HH; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Tijans AM; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Terwindt AL; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Brunekreeft KL; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Plat A; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Klip HG; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Eggink FA; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Leffers N; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Helfrich W; University of Groningen, University Medical Center Groningen, Department of Surgery, The Netherlands., Samplonius DF; University of Groningen, University Medical Center Groningen, Department of Surgery, The Netherlands., Bremer E; University of Groningen, University Medical Center Groningen, Department of Surgery, The Netherlands., Wisman GB; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., Daemen T; University of Groningen, University Medical Center Groningen, Department of Medical Microbiology, The Netherlands., Duiker EW; University of Groningen, University Medical Center Groningen, Department of Pathology, The Netherlands., Hollema H; University of Groningen, University Medical Center Groningen, Department of Pathology, The Netherlands., Nijman HW; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands., de Bruyn M; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, The Netherlands.

المصدر: Oncotarget [Oncotarget] 2016 Nov 15; Vol. 7 (46), pp. 75130-75144.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes* , Lymphocytes, Tumor-Infiltrating*, Antigens, CD/*metabolism , Integrin alpha Chains/*metabolism , Intraepithelial Lymphocytes/*immunology , Intraepithelial Lymphocytes/*metabolism , Ovarian Neoplasms/*immunology , Ovarian Neoplasms/*metabolism , Receptors, Antigen, T-Cell, alpha-beta/*metabolism, Biomarkers ; Female ; Humans ; Immunotherapy ; Immunotherapy, Adoptive ; Neoplasm Grading ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/therapy ; Phenotype ; Prognosis ; Programmed Cell Death 1 Receptor/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Receptor, Transforming Growth Factor-beta Type I ; Receptors, Transforming Growth Factor beta/metabolism ; Signal Transduction ; Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism

المؤلفون: Brunekreeft KL, Strohm C, Gooden MJ, Rybczynska AA, Nijman HW, Grigoleit GU, Helfrich W, Bremer E, Siegmund D, Wajant H, de Bruyn M; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. m.de.bruyn@umcg.nl.

المصدر: Molecular cancer [Mol Cancer] 2014 Apr 17; Vol. 13, pp. 85. Date of Electronic Publication: 2014 Apr 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocytes/*drug effects , CD40 Ligand/*genetics , Dendritic Cells/*drug effects , Recombinant Fusion Proteins/*pharmacology , Single-Chain Antibodies/*genetics, Antibodies, Monoclonal, Murine-Derived/pharmacology ; Antigens, CD20/genetics ; Antigens, CD20/metabolism ; Antigens, Neoplasm/genetics ; Antigens, Neoplasm/metabolism ; Antineoplastic Agents/pharmacology ; B-Lymphocytes/metabolism ; B-Lymphocytes/pathology ; CD40 Ligand/metabolism ; Cell Adhesion Molecules/genetics ; Cell Adhesion Molecules/metabolism ; Cell Death/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Dendritic Cells/metabolism ; Dendritic Cells/pathology ; Epithelial Cell Adhesion Molecule ; Gene Expression ; HEK293 Cells ; Humans ; Molecular Targeted Therapy ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism ; Rituximab ; Single-Chain Antibodies/metabolism

المؤلفون: van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, Oude Elberink JN, Kluin-Nelemans JC, van der Veer E, de Monchy JG

المصدر: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2013 May; Vol. 131 (5), pp. 1429-31.e1. Date of Electronic Publication: 2012 Dec 06.

نوع المنشور: Letter

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Mastocytosis, Systemic/*epidemiology, Adolescent ; Adult ; Age Factors ; Aged ; Female ; Humans ; Male ; Mastocytosis, Systemic/diagnosis ; Middle Aged ; Netherlands/epidemiology ; Prevalence ; Young Adult